Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Aldosterone and Potassium in Heart Failure
Author(s): Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Hyperkalaemia in the Cardiorenal Patient - Navigating Guidelines & Real-World Data
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 4 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Prevention & Chronic Conditions

Heart Failure
The Aldosterone Story: New Chapters
Author(s): Vijay Chopra Added: 8 months ago

Heart Failure
Constructing Practical Pathways for RAASi Management: A Review of Emerging Data
Author(s): Anjay Rastogi , Shelley Zieroth Added: 1 year ago
In this peer-to-peer discussion, Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Shelley Zieroth (University of Manitoba, CA) summarise and distil emerging real-world data on modern practices and approaches to treating hyperkalaemia during RAASi therapy in cardiorenal patients to optimise RAASI therapy.Download the Free Infographic View more

Cardiovascular Renal Metabolic

Heart Failure
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 1 year ago

MI/ACS

Heart Failure
AHA 24 Late-Breaking Discussion: REALIZE-K
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 1 year ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Low-Dose Triple Pill vs Monotherapy for Hypertension
Added: 1 month ago Source:  Cardiac Failure Review
Single-pill low-dose combination (LDC) therapy is an emerging strategy for improving blood pressure (BP) control in patients with hypertension.¹ Two new phase III trials, HM-APOLLO-301 and HM-APOLLO-302, have evaluated the efficacy and safety of an ultra-low-dose triple combination pill compared with standard-dose monotherapy as an initial treatment for mild-to-moderate hypertension… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Research Area(s) / Expertise: Job title: Nephrologist
Dr Areef Ishani is a Nephrologist and Director of the Primary and Specialty Care Service Line atMinneapolis VA Health Care System, Minneapolis, MN, US. His areas of expertise are chronic kidney disease, end-stage renal disease, high potassium level, small lymphocytic lymphoma, and kidney transplant. View more